These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26885437)

  • 61. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology].
    Hadaschik E; Eming R; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D; Enk A
    Hautarzt; 2020 Jul; 71(7):542-552. PubMed ID: 32435817
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC; Brenner T; Fuchs S
    Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases].
    Lipsker D; Lenormand C
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):459-67. PubMed ID: 22721478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunoglobulin use in immune deficiency and autoimmune disease states.
    Perez EE
    Am J Manag Care; 2019 Jun; 25(6 Suppl):S92-S97. PubMed ID: 31318514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biologics and immunoglobulins in the treatment of pyoderma gangrenosum - analysis of 52 patients.
    Herberger K; Dissemond J; Brüggestrat S; Sorbe C; Augustin M
    J Dtsch Dermatol Ges; 2019 Jan; 17(1):32-41. PubMed ID: 30592563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
    Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum or breast milk immunoglobulins mask the self-reactivity of human natural IgG antibodies.
    Djoumerska-Alexieva I; Manoylov I; Dimitrov JD; Tchorbanov A
    APMIS; 2014 Apr; 122(4):329-40. PubMed ID: 23937153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Critical decisions in selecting an intravenous immunoglobulin product.
    Gelfand EW
    J Infus Nurs; 2005; 28(6):366-74. PubMed ID: 16304494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose intravenous immunoglobulins for lupus nephritis--a salvage immunomodulation.
    Rauova L; Lukac J; Levy Y; Rovensky J; Shoenfeld Y
    Lupus; 2001; 10(3):209-13. PubMed ID: 11315354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Deficiencies in humoral immunity].
    Brémard-Oury C
    Ann Pediatr (Paris); 1989 Jun; 36(6):357-64. PubMed ID: 2667425
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease.
    Hallowell RW; Amariei D; Danoff SK
    Ann Am Thorac Soc; 2016 Oct; 13(10):1682-1688. PubMed ID: 27482830
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of disodium cromoglycate (DSCG) on the levels of albumin and the immunoglobulins IgA, IgG, IgM and IgE in sputum.
    Turner KJ; Rebuck AS
    Clin Allergy; 1975 Mar; 5(1):59-67. PubMed ID: 830058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases.
    De Ranieri D; Fenny NS
    Pediatr Ann; 2017 Jan; 46(1):e8-e12. PubMed ID: 28079912
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [TITLE].
    Gurina OP; Stepanova AA; Dementieva EA; Blinov AE; Varlamova ON; Blinov GA
    Klin Lab Diagn; 2018; 63(1):44-50. PubMed ID: 30550091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analyzing titers of antibodies against bacterial and viral antigens, and bacterial toxoids in the intravenous immunoglobulins utilized in Taiwan.
    Wu CY; Wang HC; Wang KT; Yang-Chih Shih D; Lo CF; Wang DY
    Biologicals; 2013 Mar; 41(2):88-92. PubMed ID: 23149017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.